Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | SLNO | Common Stock | 28.7K | Aug 26, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | SLNO | Employee stock option (right to buy) | 5.74K | Aug 26, 2022 | Common Stock | 5.74K | $535.50 | Direct | F3, F4 | |||||
holding | SLNO | Employee stock option (right to buy) | 2.87K | Aug 26, 2022 | Common Stock | 2.87K | $135.00 | Direct | F3, F4 | |||||
holding | SLNO | Employee stock option (right to buy) | 2K | Aug 26, 2022 | Common Stock | 2K | $349.50 | Direct | F3, F4 | |||||
holding | SLNO | Employee stock option (right to buy) | 4K | Aug 26, 2022 | Common Stock | 4K | $120.75 | Direct | F3, F4 | |||||
holding | SLNO | Employee stock option (right to buy) | 4.02K | Aug 26, 2022 | Common Stock | 4.02K | $90.00 | Direct | F3, F4 | |||||
holding | SLNO | Employee stock option (right to buy) | 22.5K | Aug 26, 2022 | Common Stock | 22.5K | $44.25 | Direct | F3, F4 | |||||
holding | SLNO | Employee stock option (right to buy) | 26.7K | Aug 26, 2022 | Common Stock | 26.7K | $24.00 | Direct | F4, F5 | |||||
holding | SLNO | Employee stock option (right to buy) | 16.7K | Aug 26, 2022 | Common Stock | 16.7K | $25.05 | Direct | F5, F6 | |||||
holding | SLNO | Employee stock option (right to buy) | 23.3K | Aug 26, 2022 | Common Stock | 23.3K | $51.15 | Direct | F5, F7 | |||||
holding | SLNO | Employee stock option (right to buy) | 140K | Aug 26, 2022 | Common Stock | 140K | $33.60 | Direct | F5, F8 | |||||
holding | SLNO | Employee stock option (right to buy) | 40.7K | Aug 26, 2022 | Common Stock | 40.7K | $5.10 | Direct | F5, F9 | |||||
holding | SLNO | Employee stock option (right to buy) | 73.3K | Aug 26, 2022 | Common Stock | 73.3K | $2.60 | Direct | F5, F10 |
Id | Content |
---|---|
F1 | The number of shares beneficially owned reflects the 1-for-15 reverse stock split effected August 26, 2022. |
F2 | Certain of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock, subject to the applicable vesting schedule and conditions of each RSU. |
F3 | The per share exercise price and number of shares subject to the option reflect the 1-for-5 reverse stock split effected October 15, 2017 and the 1-for-15 reverse stock split effected August 26, 2022. |
F4 | All of the shares subject to this option are fully vested and exercisable as of the date hereof. |
F5 | The per share exercise price and number of shares subject to the option reflect the 1-for-15 reverse stock split effected August 26, 2022. |
F6 | One forty-eighth (1/48) of the shares subject to the Option shall vest on the first month anniversary of January 24, 2019 (the "Vesting Commencement Date") and one forty-eighth (1/48) of the total number of shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person continuing to be a Service Provider through each such date. |
F7 | One forty-eighth (1/48) of the shares subject to the Option shall vest on the first month anniversary of May 18, 2020 (the "Vesting Commencement Date") and one forty-eighth (1/48) of the total number of shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date, such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person continuing to be a Service Provider through each such date. |
F8 | Twelve and one-half percent (12.5%) of the shares subject to the Option shall vest upon the date following the acceptance by the US FDA of an NDA submission for DCCR, twelve and one-half percent (12.5%) of the shares subject to the Option shall vest upon the submission by the Company to the European Medicines Agency European of an MAA for DCCR, and one forty-eighth (1/48th) of the remaining shares subject to the Option shall vest each month anniversary of January 8, 2021 (the "Vesting Commencement Date") on the same day of the month as the Vesting Commencement Date, subject to the Reporting Person continuing to be a Service Provider through each such date. |
F9 | One forty-eighth (1/48th) of the shares subject to the Option shall vest on the first month anniversary of January 1, 2022 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person continuing to be a Service Provider through each such date. |
F10 | One fourth of the shares subject to the option shall vest on August 1, 2022 and each three-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider through each such date. |